The COVID-19 pipeline: An unprecedented global clinical development effort

Posted by Kristyn Feldman on Mon, Apr 06, 2020

Parul Rewari, Cody Powers and Judith Kulich co-wrote this blog post with Kristyn Feldman.

The global COVID-19 pandemic continues to dominate headlines, including near constant updates from the pharma industry and academic clinical researchers the world over. Last week, we looked at the clinical-stage programs aimed to address the novel coronavirus. This week, we have expanded our analysis to include a wider range of clinical programs, including phase IV studies, and additional sources of data regarding this quickly evolving landscape.


>
Read More

COVID-19 Clinical Development: What's in the Pipeline to Address the SARS-CoV-2 Pandemic?

Posted by Kristyn Feldman on Tue, Mar 24, 2020

Parul Rewari, Cody Powers and Judith Kulich co-wrote this blog post with Kristyn Feldman.

As nations around the globe are hit hard by the novel coronavirus pandemic, many are asking the same question: What treatments or preventions are in the pipeline that may address COVID-19? Researchers the world over have launched numerous research, preclinical and clinical-stage programs in an effort to identify vaccines and treatments that can tackle the virus or to find treatments that mediate the downstream effects of the virus.


>
Read More

Clinical Development Risks and Issues in a COVID-19 World

Posted by Jonathan Rowe on Fri, Mar 20, 2020

Global clinical guidelines have shifted the industry toward risk-based approaches for the planning and execution of clinical trials. The ICH’s guidelines for Good Clinical Practice state that sponsors should evaluate identified risks against existing risk controls by considering “the likelihood of errors occurring, the extent to which such errors would be detectable, and the impact of such errors on human subject protection and reliability of trial results” (ICH E6 R2).


>
Read More

Now I Know What It Means to Be a Rock Star

Posted by Michael Thomas on Wed, Jun 12, 2019

The lights go down. The crowd erupts in anticipation. An iconic rock band is about to step on stage, and you are about to take part in an immersive, overwhelming experience for the next three hours. I love this moment, and I’ve always wondered what it must be like on that stage, knowing that people are so inspired by what I do. 


>
Read More

Collaboration in Clinical Operations: Three Takeaways From SCOPE 2018

Posted by Qin Ye on Fri, Mar 02, 2018

Abhay Jha and Venkat Sethuraman co-wrote this blog post with Qin Ye.

More people than ever before attended the ninth-annual Summit for Clinical Ops Executives (SCOPE)—a testament to the growing importance of innovation within clinical development. Attendees from across life sciences gathered in Orlando Feb. 12-15 to discuss clinical development challenges and solutions, and to network with peers and partners.


>
Read More